Results 121 to 130 of about 5,641 (130)

Sa1602 THE UTILITY OF AMAP SCORE IN PREDICTING HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED NON-ALCOHOLIC FATTY LIVER DISEASE

Gastroenterology, 2023
Chinmay Bera, Heather M. Kosick, Mohamed Shengir, Oyedele Adeyi, Giada Sebastiani, Keyur Patel   +5 more
openaire   +1 more source

Baseline cirrhosis in addition to the aMAP score, increased the risk of developing hepatocellular carcinoma in patients with hepatitis B

Journal of Hepatology, 2023
Supakorn Chaiwiriyawong, Pimsiri Sripongpun, Naichaya Chamroonkul, Apichat Kaewdech   +3 more
openaire   +1 more source

GALAD score outperforms aMAP and ALBI scores in the 5- and 10-year prediction of hepatocellular carcinoma (HCC) development in patients with compensated advanced chronic liver disease (cACLD): a 12-year prospective study

Journal of Hepatology, 2023
Baldaccini, Valentina, Ascari, Sara, Critelli, Rosina Maria, Pesole, Letizia, Lasagni, Simone, Coletta, Sergio, Tedesco, Calogero Claudio, Pasculli, Giuseppe, Donghia, Rossella, Semellini, Filippo, Villa, Erica, Giannelli, Gianluigi   +11 more
openaire   +1 more source

P54 Historic aMAP scores at one-year and 5-years prior to diagnosis of Hepatocellular Carcinoma (HCC) show significant differences between male and female patients

Poster presentations, 2023
Avisnata Das, Nicole George, Benjamin Giles, Joanna Dowman, Andrew Fowell, Richard Aspinall   +5 more
openaire   +1 more source

IDDF2022-ABS-0073 HCC surveillance program in a nurse-led clinic: assessing adherence to guidelines and possibility of reducing pressure on services by applying AMAP score

Clinical Hepatology, 2022
Mohamed Elnagar, Muhammad Saleem, Alison Beard, Samantha Whyld, Andrew Austin   +4 more
openaire   +1 more source

OP13 High-risk aMAP scores are present in a majority of Hepatocellular Carcinoma (HCC) patients not undergoing prior routine ultrasound-based screening, at both one and five years before HCC diagnosis

Abstracts, 2022
Avisnata Das, Benjamin Giles, Joanna Dowman, Andrew Fowell, Richard Aspinall   +4 more
openaire   +1 more source

Exploring the role of aMAP and Toronto score: beyond diagnosis to prognosis

Digestive and Liver Disease
A. Cespiati, D. Smith, C. Bertelli, R. Lombardi, A.L. Fracanzani   +4 more
openaire   +1 more source

THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Journal of Hepatology
Mathew Vithayathil, Antonio D'Alessio, Claudia Fulgenzi, Ciro Celsa, Giulia Manfredi, Naoshi Nishida, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Chun-yen Lin, Arndt Vogel, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Valentina Zanuso, Tiziana Pressiani, Giuseppe Cabibbo, Andrea Dalbeni, Matthias Pinter, Amit Singal, Hong Jae Chon, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma   +38 more
openaire   +1 more source

P224 Evaluating the performance of aMAP scores in predicting hepatocellular carcinoma development in cirrhosis patients over a three-year period

Posters
Arash Akhavan Rezayat, Avisnata Das, Benjamin Giles, Kirsty Fancey, Karen Gamble, Michelle Padgett, Aqeel Jamil, Joanna Dowman, Andrew Fowell, Richard Aspinall   +9 more
openaire   +1 more source

P61 aMAP scores at 3-years preceding hepatocellular carcinoma (HCC) diagnosis are higher in patients with steatotic liver disease compared to chronic viral hepatitis in a Southwest UK population

P61 aMAP scores at 3-years preceding hepatocellular carcinoma (HCC) diagnosis are higher in patients with steatotic liver disease compared to chronic viral hepatitis in a Southwest UK population
Laura Backhouse, Zin Oo, David Corkey, Simon Mitchell, Kushala Abeysekera, Gautham Appanna   +5 more
openaire   +1 more source